Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-29

Clinical Trial Update: End-Tidal Carbon Dioxide as a Measure of Carboxyhemoglobin in Carbon Monoxide Poisoning

View source ↗

Summary

A completed clinical trial evaluated end-tidal carbon dioxide as a potential measure of carboxyhemoglobin in individuals with carbon monoxide poisoning.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hennepin Healthcare Research Institute | Conditions: Carbon Monoxide Exposure | Status: COMPLETED